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Abstract

Results

Discussion

Most patients undergo traditional open surgery (OSR) for medical
management of abdominal aortic aneurysms (AAA), but this is often
associated with prolonged in-hospital recovery and is contraindicated in an
aging population with higher prevalence of comorbidities. Some clinicians
have turned towards the less invasive endovascular aneurysm repair
(EVAR) procedure as another option for AAA management. However, there
seems to be some conflicting research about EVAR’s long term efficacy.
Therefore, this review will analyze the efficacy and rate of complications of
EVAR compared to traditional OSR in patients 60 y.o. and older with AAA.

The six articles that were selected include two randomized
controlled trials (RCT) and four cohort studies. These studies
used common outcome measurements to compare the results
between the two procedures including survival rates > 1-year
post-op, length of hospital stay, major adverse events,
mortality rates within 30 days post-op, and rates of
reintervention.
Becquemin et al (2011) found that EVAR was associated
with advantages such as shorter hospital stays, fewer major
complications, and similar survival benefit to OSR. Raval et al
((2010) revealed elderly patients who underwent OSR had a
greater risk of developing infectious, pulmonary, cardiac, and
renal complications compared to the EVAR group.
Schermerhorn et al (2008) found that all major medical
complications, including MI and pneumonia, were less likely
after EVAR repair than after OSR. However, in the same study,
they also found reinterventions related to AAA were more
common in EVAR than in OSR.
The six studies provided different, but mostly positive
reviews on the efficacy and safety of EVAR as an alternative
treatment for AAA.

The results from the six studies in this analysis provided mixed reviews
on the efficacy and safety of EVAR compared to OSR. Most of the studies
compared the post-op results from FEVAR/EVAR vs. OSR from 30 days to a
couple of years. Most found that length of hospital stay for the initial
procedure was significantly lower in patients who underwent EVAR
compared to OSR. Studies also revealed that EVAR is related to a decrease
in major adverse events than OSR. This means that many of the EVAR
participants experienced greater short-term survival benefits.
However, most of the studies did not find a significant reduction of
survival rates past one year for endovascular repair, nor did they find a
decrease in reintervention rates between the two treatments. There was
also mixed consensus about rate of perioperative mortality within 30 days,
which could be influenced by surgeon’s technique, limitations of the
surgical centers, and patient’s comorbidities and access to healthcare.
This shows that EVAR might have better short and mid-term benefits,
but long-term outcomes are similar if not worse than OSR.
The results that were collected and analyzed from the six studies have
shown optimistic data on the short-term and mid-term benefits of EVAR for
treatment of AAA. However, due to several limitations, such as inability to
exclude bias, small sample size, short-term follow up periods, and lack of
randomization, the data most likely cannot provide a great defense for
positive long-term outcomes in (F)EVAR.

Introduction
An abdominal aortic aneurysm (AAA) is a local dilation of the abdominal
aorta that occurs when the pressure from inside the artery causes the
weakened area to bulge out beyond the normal width of the blood vessel.
Initial presentation of AAA is usually asymptomatic. If left untreated, the
diameter of the aneurysm can become wider, which can result in an
increased risk of rupture and death. AAA is traditionally treated by OSR, but
this procedure is highly invasive and can lead to prolonged in-hospital
recovery, increased rate of reinterventions, and other major adverse events
such as MI, respiratory failure, and stroke. EVAR is a minimally invasive
procedure with promising results such as short-term hospital stays, lower
perioperative complications, and decreased morbidity. However, very few
studies have focused on the long-term effects of endografts in AAA.

Table 1. Comparison of Results: EVAR/FEVAR vs. OSR
Study

Methods
• A literature search was completed though PubMed, ClinicalKey, and Google
Scholar.
• Keywords:
• FEVAR; AAA; Open surgery; treatment; Medicare; Repair;
Endovascular vs. Open Repair; Ruptured AAA; randomized
controlled trial; hospital stay, long-term outcome; early
outcome
• Results yielded: 351 articles
• Exclusion criteria:
• Articles published 10+ years ago, patients under 60 y.o.,
systematic review, cost-effectiveness of procedures, studies that
did not measure length of hospital stay, articles not exclusively
comparing outcomes from OSR vs. EVAR/FEVAR, studies that did
not include reinterventions or readmissions after the initial
procedures.
• Six articles were selected after application of exclusion criteria.
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Conclusion
Current research provides mostly positive reviews on the efficacy and
safety of EVAR as an alternative treatment for AAA. Compared with OSR,
EVAR has proven itself to offer advantages of shorter hospital stays, fewer
major complications, and similar survival benefit to OSR. However, in midterm and long-term reviews, late complications from EVAR, which includes
increased rates of graft-related complications and higher rates of
reintervention, were found more likely to occur in patients between the
ages of 60-79 years old. More research needs to be conducted to provide
sufficient evidence that affirms EVAR as an effective and reliable alternative
to OSR in the elective treatment of AAA.
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